Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
Pesticide Biochemistry and Physiology|March 8, 2024
Molybdenum inhibited the growth of Phytophthora nicotiana and improved the resistance of Nicotiana tabacum L. against tobacco black shankBingjie Yu, Junling Li, Mohamed G Moussa, et al.
ACS Omega|February 1, 2021
Synthesis of Radiolabeled Technetium- and Rhenium-Luteinizing Hormone-Releasing Hormone (99mTc/Re-Acdien-LHRH) Conjugates for Targeted Detection of Breast Cancer Cells Overexpressing the LHRH ReceptorLindsay E Calderon, Carrie A Black, Joseph D Rollins, et al.
Thoracic Cancer|December 1, 2021
Clinical outcome, long-term survival and tolerability of sequential therapy of first-line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in ChinaZihua Zou, Xuezhi Hao, Cuiying Zhang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 25, 2016
[Efficacy of Cetuximab in Combination with Chemotherapy in Advanced Non-small Cell Lung Cancer]Sheng Yang, Yan Wang, Xingsheng Hu, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Identification of MET exon14 skipping by targeted DNA- and RNA-based next-generation sequencing in pulmonary sarcomatoid carcinomasYan Li, Lianju Gao, Di Ma, et al.
Targeted Oncology|April 27, 2019
Efficacy of Crizotinib for Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Patients with Brain Metastasis: A Multicenter, Retrospective Study in ChinaPuyuan Xing, Shouzheng Wang, Qiang Wang, et al.
The Science of the Total Environment|November 12, 2023
Nonlinear effect of NOx concentration decrease on secondary aerosol formation in the Beijing-Tianjin-Hebei region: Evidence from smog chamber experiments and field observationsJunling Li, Tianzeng Chen, Hao Zhang, et al.
Translational Lung Cancer Research|May 19, 2025
Effect of the number of induction chemotherapy cycles on the efficacy of first-line atezolizumab combined with chemotherapy in extensive-stage small cell lung cancerMengxing You, Jiayu Liu, Fei Teng, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2002
Succinimide hydroxamic acids as potent inhibitors of histone deacetylase (HDAC)Michael L Curtin, Robert B Garland, H Robin Heyman, et al.
Eclinicalmedicine|October 28, 2025
Long-term outcomes of postoperative radiotherapy for patients with pIIIA-N2 non-small-cell lung cancer after complete resection and adjuvant chemotherapy (PORT-C): a single-centre, randomized, phase 3 trialYu Men, Yongxing Bao, Nan Bi, et al.
Pageof 32